APO Research

APO RESEARCH · REPORT

Matrine for Injection

Selected research

Industry Growth & Trends

Global Matrine for Injection Industry Growth and Trends Forecast to 2032

Market perspective

The global Matrine for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Matrine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Matrine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Matrine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Matrine for Injection include Chengdu Tiantai Mount Pharmaceutical, Henan Rongcheng Pharmaceutical, Jiuquan Dadeli Pharmaceutical, Nirvana Pharmaceutical, Trifecta Pharma Co. Ltd and CTTQ PHARMA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Matrine for Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Matrine for Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Matrine for Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Matrine for Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Matrine for Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Matrine for Injection Market by Company

Chengdu Tiantai Mount Pharmaceutical

Henan Rongcheng Pharmaceutical

Jiuquan Dadeli Pharmaceutical

Nirvana Pharmaceutical

Trifecta Pharma Co. Ltd

CTTQ PHARMA

Matrine for Injection Segment by Type

Intramuscular Injection

Intravenous Drip

Matrine for Injection Segment by Application

Chronic Hepatitis B Treatment

Tumor Radiotherapy

Others

Matrine for Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Matrine for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Matrine for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Matrine for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Matrine for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Matrine for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intramuscular Injection Table 2. Major Company of Intravenous Drip Table 3. Global Matrine for Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Matrine for Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Matrine for Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Matrine for Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Matrine for Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Matrine for Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Matrine for Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Matrine for Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Matrine for Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Matrine for Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Matrine for Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Matrine for Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Matrine for Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Matrine for Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Matrine for Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Matrine for Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Matrine for Injection Industry Trends Table 25. Matrine for Injection Industry Drivers Table 26. Matrine for Injection Industry Opportunities and Challenges Table 27. Matrine for Injection Industry Restraints Table 28. Global Matrine for Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Matrine for Injection Revenue Market Share by Company (2021-2026) Table 30. Global Matrine for Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Matrine for Injection Sales Share by Company (2021-2026) Table 32. Global Matrine for Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Matrine for Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Matrine for Injection Major Company Production Sites and Headquarters Table 35. Global Matrine for Injection Company, Product Type & Application Table 36. Global Matrine for Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Matrine for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Matrine for Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Matrine for Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Matrine for Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Matrine for Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Matrine for Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Matrine for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Matrine for Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Matrine for Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Matrine for Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Matrine for Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Matrine for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Matrine for Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Matrine for Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Matrine for Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Matrine for Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Matrine for Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Matrine for Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Matrine for Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Matrine for Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Matrine for Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Matrine for Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Matrine for Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Matrine for Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Matrine for Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Matrine for Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Matrine for Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Matrine for Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Chengdu Tiantai Mount Pharmaceutical Company Information Table 72. Chengdu Tiantai Mount Pharmaceutical Business Overview Table 73. Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Product Portfolio Table 75. Chengdu Tiantai Mount Pharmaceutical Recent Development Table 76. Henan Rongcheng Pharmaceutical Company Information Table 77. Henan Rongcheng Pharmaceutical Business Overview Table 78. Henan Rongcheng Pharmaceutical Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Henan Rongcheng Pharmaceutical Matrine for Injection Product Portfolio Table 80. Henan Rongcheng Pharmaceutical Recent Development Table 81. Jiuquan Dadeli Pharmaceutical Company Information Table 82. Jiuquan Dadeli Pharmaceutical Business Overview Table 83. Jiuquan Dadeli Pharmaceutical Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Jiuquan Dadeli Pharmaceutical Matrine for Injection Product Portfolio Table 85. Jiuquan Dadeli Pharmaceutical Recent Development Table 86. Nirvana Pharmaceutical Company Information Table 87. Nirvana Pharmaceutical Business Overview Table 88. Nirvana Pharmaceutical Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Nirvana Pharmaceutical Matrine for Injection Product Portfolio Table 90. Nirvana Pharmaceutical Recent Development Table 91. Trifecta Pharma Co. Ltd Company Information Table 92. Trifecta Pharma Co. Ltd Business Overview Table 93. Trifecta Pharma Co. Ltd Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Trifecta Pharma Co. Ltd Matrine for Injection Product Portfolio Table 95. Trifecta Pharma Co. Ltd Recent Development Table 96. CTTQ PHARMA Company Information Table 97. CTTQ PHARMA Business Overview Table 98. CTTQ PHARMA Matrine for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. CTTQ PHARMA Matrine for Injection Product Portfolio Table 100. CTTQ PHARMA Recent Development Table 101. North America Matrine for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Matrine for Injection Sales by Country (2021-2026) & (K Units) Table 103. North America Matrine for Injection Sales Market Share by Country (2021-2026) Table 104. North America Matrine for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Matrine for Injection Sales Market Share Forecast by Country (2027-2032) Table 106. North America Matrine for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Matrine for Injection Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Matrine for Injection Market Share by Country (2021-2026) Table 109. North America Matrine for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Matrine for Injection Market Share Forecast by Country (2027-2032) Table 111. Europe Matrine for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Matrine for Injection Sales by Country (2021-2026) & (K Units) Table 113. Europe Matrine for Injection Sales Market Share by Country (2021-2026) Table 114. Europe Matrine for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Matrine for Injection Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Matrine for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Matrine for Injection Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Matrine for Injection Market Share by Country (2021-2026) Table 119. Europe Matrine for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Matrine for Injection Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Matrine for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Matrine for Injection Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Matrine for Injection Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Matrine for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Matrine for Injection Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Matrine for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Matrine for Injection Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Matrine for Injection Market Share by Country (2021-2026) Table 129. Asia-Pacific Matrine for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Matrine for Injection Market Share Forecast by Country (2027-2032) Table 131. Latin America Matrine for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Matrine for Injection Sales by Country (2021-2026) & (K Units) Table 133. Latin America Matrine for Injection Sales Market Share by Country (2021-2026) Table 134. Latin America Matrine for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Matrine for Injection Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Matrine for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Matrine for Injection Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Matrine for Injection Market Share by Country (2021-2026) Table 139. Latin America Matrine for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Matrine for Injection Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Matrine for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Matrine for Injection Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Matrine for Injection Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Matrine for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Matrine for Injection Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Matrine for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Matrine for Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Matrine for Injection Market Share by Country (2021-2026) Table 149. Middle East and Africa Matrine for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Matrine for Injection Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Matrine for Injection Distributors List Table 154. Matrine for Injection Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Matrine for Injection Image Figure 2. Global Matrine for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Matrine for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Matrine for Injection Sales (2021-2032) & (K Units) Figure 5. Intramuscular Injection Image Figure 6. Global Intramuscular Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Intravenous Drip Image Figure 8. Global Intravenous Drip Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Matrine for Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Matrine for Injection Market Share by Type 2025 VS 2032 Figure 11. North America Matrine for Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Matrine for Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Matrine for Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Matrine for Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Matrine for Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Matrine for Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Matrine for Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Matrine for Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Matrine for Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Matrine for Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Matrine for Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Chronic Hepatitis B Treatment Image Figure 24. Global Chronic Hepatitis B Treatment Sales YoY Growth (2021-2032) & (K Units) Figure 25. Tumor Radiotherapy Image Figure 26. Global Tumor Radiotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Matrine for Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Matrine for Injection Market Share by Application 2025 VS 2032 Figure 31. North America Matrine for Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Matrine for Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Matrine for Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Matrine for Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Matrine for Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Matrine for Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Matrine for Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Matrine for Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Matrine for Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Matrine for Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Matrine for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Matrine for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Matrine for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Matrine for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Matrine for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Matrine for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Matrine for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Matrine for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Matrine for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Matrine for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Matrine for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Matrine for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Matrine for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Matrine for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Matrine for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Matrine for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Matrine for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Matrine for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Matrine for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Matrine for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Matrine for Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Matrine for Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Injection
  • Intravenous Drip
Applications
  • Chronic Hepatitis B Treatment
  • Tumor Radiotherapy
  • Others
Companies covered
  • Chengdu Tiantai Mount Pharmaceutical
  • Henan Rongcheng Pharmaceutical
  • Jiuquan Dadeli Pharmaceutical
  • Nirvana Pharmaceutical
  • Trifecta Pharma Co. Ltd
  • CTTQ PHARMA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Matrine for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Matrine for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Matrine for Injection Market by Type
  6. 1.3.1 Intramuscular Injection
  7. 1.3.2 Intravenous Drip
  8. 1.4 Global Matrine for Injection Market Size by Type
  9. 1.4.1 Global Matrine for Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Matrine for Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Matrine for Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Matrine for Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Matrine for Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Matrine for Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Matrine for Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Matrine for Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Matrine for Injection Industry Trends
  2. 2.2 Matrine for Injection Industry Drivers
  3. 2.3 Matrine for Injection Industry Opportunities and Challenges
  4. 2.4 Matrine for Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Matrine for Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Matrine for Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Matrine for Injection Price (2021-2026)
  4. 3.4 Global Matrine for Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Matrine for Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Matrine for Injection Company, Product Type & Application
  7. 3.7 Global Matrine for Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Matrine for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Matrine for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Matrine for Injection Tier 1, Tier 2, and Tier 3
4 Matrine for Injection Regional Status and Outlook
  1. 4.1 Global Matrine for Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Matrine for Injection Historic Market Size by Region
  3. 4.2.1 Global Matrine for Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Matrine for Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Matrine for Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Matrine for Injection Forecasted Market Size by Region
  7. 4.3.1 Global Matrine for Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Matrine for Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Matrine for Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Matrine for Injection by Application
  1. 5.1 Matrine for Injection Market by Application
  2. 5.1.1 Chronic Hepatitis B Treatment
  3. 5.1.2 Tumor Radiotherapy
  4. 5.1.3 Others
  5. 5.2 Global Matrine for Injection Market Size by Application
  6. 5.2.1 Global Matrine for Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Matrine for Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Matrine for Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Matrine for Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Matrine for Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Matrine for Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Matrine for Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Matrine for Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chengdu Tiantai Mount Pharmaceutical
  2. 6.1.1 Chengdu Tiantai Mount Pharmaceutical Company Information
  3. 6.1.2 Chengdu Tiantai Mount Pharmaceutical Business Overview
  4. 6.1.3 Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Product Portfolio
  6. 6.1.5 Chengdu Tiantai Mount Pharmaceutical Recent Developments
  7. 6.2 Henan Rongcheng Pharmaceutical
  8. 6.2.1 Henan Rongcheng Pharmaceutical Company Information
  9. 6.2.2 Henan Rongcheng Pharmaceutical Business Overview
  10. 6.2.3 Henan Rongcheng Pharmaceutical Matrine for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Henan Rongcheng Pharmaceutical Matrine for Injection Product Portfolio
  12. 6.2.5 Henan Rongcheng Pharmaceutical Recent Developments
  13. 6.3 Jiuquan Dadeli Pharmaceutical
  14. 6.3.1 Jiuquan Dadeli Pharmaceutical Company Information
  15. 6.3.2 Jiuquan Dadeli Pharmaceutical Business Overview
  16. 6.3.3 Jiuquan Dadeli Pharmaceutical Matrine for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiuquan Dadeli Pharmaceutical Matrine for Injection Product Portfolio
  18. 6.3.5 Jiuquan Dadeli Pharmaceutical Recent Developments
  19. 6.4 Nirvana Pharmaceutical
  20. 6.4.1 Nirvana Pharmaceutical Company Information
  21. 6.4.2 Nirvana Pharmaceutical Business Overview
  22. 6.4.3 Nirvana Pharmaceutical Matrine for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nirvana Pharmaceutical Matrine for Injection Product Portfolio
  24. 6.4.5 Nirvana Pharmaceutical Recent Developments
  25. 6.5 Trifecta Pharma Co. Ltd
  26. 6.5.1 Trifecta Pharma Co. Ltd Company Information
  27. 6.5.2 Trifecta Pharma Co. Ltd Business Overview
  28. 6.5.3 Trifecta Pharma Co. Ltd Matrine for Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Trifecta Pharma Co. Ltd Matrine for Injection Product Portfolio
  30. 6.5.5 Trifecta Pharma Co. Ltd Recent Developments
  31. 6.6 CTTQ PHARMA
  32. 6.6.1 CTTQ PHARMA Company Information
  33. 6.6.2 CTTQ PHARMA Business Overview
  34. 6.6.3 CTTQ PHARMA Matrine for Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 CTTQ PHARMA Matrine for Injection Product Portfolio
  36. 6.6.5 CTTQ PHARMA Recent Developments
7 North America by Country
  1. 7.1 North America Matrine for Injection Sales by Country
  2. 7.1.1 North America Matrine for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Matrine for Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Matrine for Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Matrine for Injection Market Size by Country
  6. 7.2.1 North America Matrine for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Matrine for Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Matrine for Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Matrine for Injection Sales by Country
  2. 8.1.1 Europe Matrine for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Matrine for Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Matrine for Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Matrine for Injection Market Size by Country
  6. 8.2.1 Europe Matrine for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Matrine for Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Matrine for Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Matrine for Injection Sales by Country
  2. 9.1.1 Asia-Pacific Matrine for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Matrine for Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Matrine for Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Matrine for Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Matrine for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Matrine for Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Matrine for Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Matrine for Injection Sales by Country
  2. 10.1.1 South America Matrine for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Matrine for Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Matrine for Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Matrine for Injection Market Size by Country
  6. 10.2.1 South America Matrine for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Matrine for Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Matrine for Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Matrine for Injection Sales by Country
  2. 11.1.1 Middle East and Africa Matrine for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Matrine for Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Matrine for Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Matrine for Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Matrine for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Matrine for Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Matrine for Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Matrine for Injection Value Chain Analysis
  2. 12.1.1 Matrine for Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Matrine for Injection Production Mode & Process
  7. 12.2 Matrine for Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Matrine for Injection Distributors
  10. 12.2.3 Matrine for Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research